• 2011

Company Description

MedDay is a biotechnology company specializing in therapeutics for the treatment of neuro-metabolic diseases.

MedDay, a Paris, France-based biotech company. Founded in 2011 by Dr Frédéric Sedel and Dr Guillaume Brion, MedDay specializes in the treatment of neuro-metabolic diseases. The company’s technology platform leverages the work of Dr Frédéric Sedel, a neuroscientist at La Pitié Salpêtrière Hospital (Paris), in the area of neuropsychiatric diseases. The company is currently incubated at l’Institut du Cerveau et de la Moelle épinière in Paris (ICM).